BEATcc (ENGOT-CX10/GEICO 68-C/JGOG1084/GOG-3030), A Randomised Phase 3 Trial Of First-Line Atezolizumab With Bevacizumab And Platinum-Based Chemotherapy For Metastatic (Stage IVB), Persistent Or Recurrent Cervical Cancer

ESGO eAcademy, Ana Oaknin, 410928

Patient-Reported Outcomes From The Phase 3, Randomized, Double-Blind, Placebo-Controlled ENGOT-Cx11/GOG 3047/KEYNOTE-A18 Study Of Pembrolizumab Plus Concurrent Chemoradiotherapy In Patients With High-Risk Locally Advanced Cervical Cancer

ESGO eAcademy, Sandro Pignata, 410926

A Randomized Phase III Trial Of Induction Chemotherapy Followed By Chemoradiation Compared With Chemoradiation Alone In Locally Advanced Cervical Cancer. The GCIG INTERLACE Trial

ESGO eAcademy, Mary McCormack, 410925

Discussant

ESGO eAcademy, Toon Van Gorp, 410930

Discussant

ESGO eAcademy, Remi Nout, 410927

Discussant

ESGO eAcademy, Nadeem R. Abu-Rustum, 410924

Survival Of Patients With Early Stages Cervical Cancer After SLN Biopsy Without Systematic Pelvic Lymphadenectomy: Survival Outcomes Of The SENTIX Prospective Single-Arm International Trial (CEEGOG CX-01; ENGOT-CX2)

ESGO eAcademy, David Cibula, 410923

Immuno and Immune-Combo: Toxicity Management

ESGO eAcademy, Kathleen Moore, 410922

Is there a Place for Immune after Immuno in Endometrial Cancer (alone or in combination)?

ESGO eAcademy, Coleman Robert, 410921

Endometrial Cancer: A Paradigm Shift in the Treatment Algorithm

ESGO eAcademy, Christian Marth, 410920

The VITA MCQ Test

ESGO eAcademy, Faculty / Presenters, 410906

Ultrasound Guided Procedures (ESGO/ISUOG Consensus Statement)

ESGO eAcademy, Elisabeth Epstein, 410905

Vulvar Cancer Staging Using Ultrasound (ESGO Guidelines)

ESGO eAcademy, Daniela Fischerova, 410903

Ovarian Cancer Precision Prevention: improving ascertainment and personalised surgical approaches

ESGO eAcademy, Faculty / Presenter(s), 411368

Sentinel lymph node dissection

ESGO eAcademy, Faculty / Presenter(s), 411242

New EC FIGO staging system

ESGO eAcademy, Faculty / Presenter(s), 410593

Updates on surgical trials in gynecologic oncology

ESGO eAcademy, Faculty / Presenter(s), 410592

Systemic therapy for uterine LMS

ESGO eAcademy, Faculty / Presenter(s), 410591

Is there a role of predictive biomarkers for endocrine therapy in gynecological malignancies?

ESGO eAcademy, Faculty / Presenter(s), 410590

Olivia - digital patient pathway

ESGO eAcademy, Faculty / Presenter(s), 410589

IOTA Course With Certification: Diagnosis and Management of Ovarian Tumours

ESGO eAcademy, Faculty / Presenter(s), 410513

Minimally invasive surgery

ESGO eAcademy, Faculty / Presenter(s), 409992

Tru-cut biopsy in gynecologic oncology

ESGO eAcademy, Faculty / Presenter(s), 409991

How to scan abdomen

ESGO eAcademy, Faculty / Presenter(s), 409990

How to scan pelvis

ESGO eAcademy, Faculty / Presenter(s), 409989

IOTA terminology, subjective assessment, IOTA rules and models

ESGO eAcademy, Faculty / Presenter(s), 409988

Preoperative ultrasound evaluation of resectability of gynaecological tumours

ESGO eAcademy, Faculty / Presenter(s), 409987

Endometrial cancer staging

ESGO eAcademy, Faculty / Presenter(s), 409985

Endometrial cancer diagnosis and staging

ESGO eAcademy, Faculty / Presenter(s), 409984

Preoperative ultrasound assesment on women with endometrial cancer

ESGO eAcademy, Faculty / Presenter(s), 409983

Live scan: Cervical cancer staging

ESGO eAcademy, Faculty / Presenter(s), 409982

Cervical cancer staging

ESGO eAcademy, Faculty / Presenter(s), 409980

Live scan: Lymph node assessment in vulvar cancer

ESGO eAcademy, Faculty / Presenter(s), 409979

Ultrasound in gynaecological oncology (Introduction)

ESGO eAcademy, Faculty / Presenters, 409976

Cervical cancer staging

ESGO eAcademy, Faculty / Presenter(s), 409981

HIPEC: How to do it

ESGO eAcademy, Faculty / Presenter(s), 409966

Ovarian cancer staging

ESGO eAcademy, Faculty / Presenter(s), 409986

Cervical Cancer staging

ESGO eAcademy, Daniela Fischerova, 408338

Trends in CIN management

ESGO eAcademy, Faculty / Presenter(s), 407971

Nouvelle Treatments in Gynaecological Cancers (November 18)

ESGO eAcademy, Faculty / Presenters, 406096

Nouvelle Treatments in Gynaecological Cancers 2023 (November 17)

ESGO eAcademy, Faculty / Presenters, 406095

Pelvic side wall surgery by Vito Chiantera

ESGO eAcademy, Vito Chiantera, 405865

Most Promising New Agents in Gynecological Oncology

ESGO eAcademy, Frederik Marmé, 405207

Managing Toxicity of Combined Chemotherapy with Checkpoint Inhibitors and ADC in Gynecologic Oncology

ESGO eAcademy, Domenica Lorusso, 405206

Management of Thoracic Disease

ESGO eAcademy, Dennis Chi, 405205

Management of Stoma Complications and Timing of Replacement

ESGO eAcademy, Piero Alesina, 405204

Management of Bowel Leakage

ESGO eAcademy, Giovanni Aletti, 405202

The Ureter was Cut – What Can I Do Now?

ESGO eAcademy, Luis Chiva, 405201

Invitation to ESGO 2024 in Barcelona

ESGO eAcademy, Domenica Lorusso, 403890

Invitation to ESGO 2024 in Barcelona

ESGO eAcademy, Jordi Ponce, 403889

Young Investigator Award

ESGO eAcademy, Nicole Concin, 403888

Best Runners Awards

ESGO eAcademy, Nicole Concin, 403887

Discussant

ESGO eAcademy, Jonathan Ledermann, 403886

Hepatic Hilium Cytoreductive Surgery For Ovarian Cancer Relapse

ESGO eAcademy, Myriam Gracia, 403880

Rare Tumours Algorithms in Mobile App (Ovarian Small Cell Carcinoma)

ESGO eAcademy, Enora Laas, 403875

Quality-Adjusted Time Without Symptoms Of Disease Or Toxicity In Patients With Primary Advanced Or Recurrent Endometrial Cancer Treated With Dostarlimab Plus Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel In The ENGOT-EN6/GOG-3031/RUBY Trial

ESGO eAcademy, Dana Chase, 403885

Conservative Management of Burst Abdomen After Interval Cytoreduction Surgery of Ovarian Carcinosarcoma

ESGO eAcademy, Alberto Rafael Guijarro Campillo, 403879

Long-Term Follow Up Of Selinexor Maintenance For Patients With TP53wt Advanced Or Recurrent Endometrial Cancer: A Pre-Specified Subgroup Analysis From The Phase 3 ENGOT-EN5/GOG-3055/SIENDO Study

ESGO eAcademy, Alejandro Fidalgo, 403884

Immunotherapy in Gestational Trophoblastic Tumours: Where Next?

ESGO eAcademy, Michael Seckl, 403874

Porta Hepatis Disease In Ovarian Cancer. When Cytoreduction Is Possible.

ESGO eAcademy, Ana Conde Adán, 403878

Discussant

ESGO eAcademy, Toon Van Gorp, 403883

Hot Issues in Uterine Tumours

ESGO eAcademy, Frederic Amant, 403873

Laparoscopic Interval Debulking Surgery: Where Do We Stand and Where Do We Need to Go?

ESGO eAcademy, Andrea Rosati, 403877

Seneca Study: Staging Endometrial Cancer Based On Molecular Classification

ESGO eAcademy, ENRIQUE CHACON, 403882

Verification Of The Prognostic Precision Of The New 2023 FIGO Staging System In Endometrial Cancer Patients– An International Pooled Analysis Of Three ESGO Accredited Centers

ESGO eAcademy, Richard Schwameis, 403881

What’s New in Rare Ovarian Tumour Management?

ESGO eAcademy, Isabelle Ray-Coquard, 403872

Tumoral Clearance Of The Right Portal Hilar Area: Surprises Beyond «no Visual Disease»

ESGO eAcademy, Ghanim Khatib, 403876

Future Potential and Opportunities of the ESGO Database

ESGO eAcademy, Ane Gerda Eriksson, 403912

The Near Future - Novel Therapies, Especially Immunotherapy

ESGO eAcademy, Mansoor Raza Mirza, 403869

Initial Results From The ESGO-Accredited Center Consortium Founding Project “Assessment Of The Prognostic Impact Of The Published ESGO Quality Indicators For Advanced Ovarian Cancer Surgery”

ESGO eAcademy, Christoph Grimm, 403871

The Current Modalities - Radiotherapy, Chemotherapy, Both?

ESGO eAcademy, Nicoletta Colombo, 403868

ESGO Vision for an International Database on Gynaecological Malignancies

ESGO eAcademy, Nicole Concin, 403870

CON Opinion

ESGO eAcademy, Denis Querleu, 403866

PRO Opinion

ESGO eAcademy, Henrik Falconer, 403865

ESGO-ESTRO-ESP Consensus Guidelines - Evidence Behind

ESGO eAcademy, Sturdza Alina Emiliana, 403867

State of the Art of SLN in Ovarian Cancer

ESGO eAcademy, Alessandro Buda, 403856

ESGO Opportunities for Prevention and Training

ESGO eAcademy, Nicole Concin, 403864

Screening Status in Azerbaijan & Central Asia and Needs for Training

ESGO eAcademy, Shamistan Aliyev, 403863

Palliative Derivation and Special Scenarios. Contribution of Fluorescence to Reduce the Rate of Complications

ESGO eAcademy, Gwenael Ferron, 403853

Screening Status in Korea & East Asian Countries and Needs for Training

ESGO eAcademy, Jae-Weon Kim, 403862

Screening Status in India & South Asian Countries and Needs for Training

ESGO eAcademy, Bhagyalaxmi Nayak, 403861

Current Status and Future of SLN in Cervical Cancer

ESGO eAcademy, Nicolò Bizzarri, 403855

Principle of Bowel Resection and Anastomosis. Role of Stoma

ESGO eAcademy, Christina Fotopoulou, 403852

Screening Status in Sub-Saharan Africa Region and Needs for Training

ESGO eAcademy, BABY CELINE TENDOBI MBAMBA BALUANDA, 403860

Screening Status in Egypt & North Africa Region and Needs for Training

ESGO eAcademy, Hesham El Ghazaly, 403859

Screening Status in Latin American Region and Needs for Training

ESGO eAcademy, René Pareja, 403858

Introduction

ESGO eAcademy, Murat Gultekin, 403857

Pitfalls Of SLN Mapping In Uterine Cancer

ESGO eAcademy, Nadeem R. Abu-Rustum, 403854

Anatomic Background To Master Bowel Surgery. Role of Bowel Preparation, General Considerations

ESGO eAcademy, Dimitrios Haidopoulos, 403851

Methylation Markers Have The Potential To Enhance The Accuracy Of Cervical Screening: An Epigenome-Wide Association Study Of 850,000 Methylation Sites

ESGO eAcademy, Sarah Bowden, 403850

Tumor-Informed CtDNA Detection As A Marker For Postoperative Residual Disease In Epithelial Ovarian Cancer – Results Of A Feasibility Study

ESGO eAcademy, Magdalena Postl, 403849

Evaluating The Effectiveness Of Ovarian Tumour Risk Assessment Strategies In A Real-World National Setting - In Collaboration With The Dutch Gynaecological Oncology Audit Collaborator Group And The PALGA Group.

ESGO eAcademy, Anna Koch, 403848

Preoperative Brachytherapy Of Early-Stage Cervical Cancer: Results Of The SFRO Brachytherapy Group Multicenter Cohort

ESGO eAcademy, Kanta KA, 403847

Updates to the Role of Surgery

ESGO eAcademy, Fagotti Anna, 403841

Treatment and Follow Up Options

ESGO eAcademy, Giovanni Scambia, 403838

Surgical Management Of FIGO Stage IV Epithelial Ovarian Cancer Versus FIGO Stage IIIC: The Real-World Experience From KEM

ESGO eAcademy, Irina Tsibulak, 403846

Proposition Of A Tailored Perioperative-Care Algorithm For Patients With Advanced-Stage Ovarian Cancer, Based On The Surgical Complexity Score (Aletti Score).

ESGO eAcademy, Elisa Scarpelli, 403845

Targeted Therapy - New Challenges for Treating Recurrent Disease

ESGO eAcademy, Antonio Gonzalez-Martin, 403840

Pathology Evaluation and the New Molecular Profile Implication

ESGO eAcademy, Xavier Matias-Guiu, 403837

Association Between Endometriosis And Endometrial Cancer: A Real World Evidence Study

ESGO eAcademy, Alberto Farolfi, 403844